Lv625
1618 积分 2024-09-08 加入
ZNF830 mediates cancer chemoresistance through promoting homologous-recombination repair
7天前
已完结
Applicability of the FDA-approved Immunohistochemical Panel for Identification of MMRd Phenotype in Uterine Endometrioid Carcinoma
9天前
已完结
GANNET53 Part II: A European Phase I/II Trial of the HSP90 inhibitor Ganetespib in high-grade Platinum-Resistant Ovarian Cancer - A Study of the GANNET53 consortium
11天前
已关闭
PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407
12天前
已完结
A first-in-class EGFR-directed KRAS G12V selective inhibitor
12天前
已关闭
Testing for homologous recombination repair or homologous recombination deficiency for poly (ADP-ribose) polymerase inhibitors: A current perspective
17天前
已完结
Prospectives and retrospectives of microfluidics devices and lab-on-A-chip emphasis on cancer
17天前
已完结
The diagnostic accuracy and prognostic implication of pelvic and peritoneal fluid cytology specimens in ovarian clear cell carcinoma
21天前
已完结
Development of an FRα Companion Diagnostic Immunohistochemical Assay for Mirvetuximab Soravtansine
1个月前
已完结
Comparative Assessment of Diagnostic Homologous Recombination Deficiency–Associated Mutational Signatures in Ovarian Cancer
1个月前
已完结
皖公网安备34019202002308
